Design
Review
Authors
Loading...
Highlights potential antiviral targets in virus-associated cardiac disease; leaves open validation in cardiovascular models.
Key points are not available for this paper at this time.
Gale et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: